A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
for Non-Small Cell Lung Cancer (NSCLC)
Drug: Sotorasib
21 locations incl. Santa Barbara
Sponsor: Amgen
Sex: All·Age: 18 - 100
Code: NCT05920356·Phase 3·Recruiting